0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as pentamidine, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase II trial is studying how well pentamidine works in treating patients with
relapsed or refractory melanoma.
Phase:
Phase 2
Details
Lead Sponsor:
Edward Sausville University of Maryland, Baltimore